Literature DB >> 21859961

Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion.

Yi-Fei Dong1, Keiichiro Kataoka, Kensuke Toyama, Daisuke Sueta, Nobutaka Koibuchi, Eiichiro Yamamoto, Kenichiro Yata, Hidekazu Tomimoto, Hisao Ogawa, Shokei Kim-Mitsuyama.   

Abstract

The role of the renin-angiotensin system in cognitive impairment is unclear. This work was undertaken to test our hypothesis that renin-angiotensin system may contribute to cognitive decline and brain damage caused by chronic cerebral ischemia. C57BL/6J mice were subjected to bilateral common carotid artery stenosis with microcoil to prepare mice with chronic cerebral hypoperfusion, a model of subcortical vascular dementia. The effects of aliskiren, a direct renin inhibitor, or Tempol, a superoxide scavenger, on brain damage and working memory in these mice were examined. Chronic cerebral hypoperfusion significantly increased brain renin activity and angiotensinogen expression in C57BL/6J mice, which was attributed to the increased renin in activated astrocytes and microvessels and the increased angiotensinogen in activated astrocytes in white matter. Aliskiren pretreatment significantly inhibited brain renin activity and ameliorated brain p67(phox)-related NADPH oxidase activity, oxidative stress, glial activation, white matter lesion, and spatial working memory deficits in C57BL/6J mice with bilateral common carotid artery stenosis. To elucidate the role of oxidative stress in brain protective effects of aliskiren, we also examined the effect of Tempol in the same mice with bilateral common carotid artery stenosis. Tempol pretreatment mimicked the brain protective effects of aliskiren in this mouse model. Posttreatment of mice with aliskiren or Tempol after bilateral common carotid artery stenosis also prevented cognitive decline. In conclusion, chronic cerebral hypoperfusion induced the activation of the brain renin-angiotensin system. Aliskiren ameliorated brain damage and working memory deficits in the model of chronic cerebral ischemia through the attenuation of oxidative stress. Thus, direct renin inhibition seems to be a promising therapeutic strategy for subcortical vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859961     DOI: 10.1161/HYPERTENSIONAHA.111.173534

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

Review 1.  Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.

Authors:  Hyun Ah Kim; Alyson A Miller; Grant R Drummond; Amanda G Thrift; Thiruma V Arumugam; Thanh G Phan; Velandai K Srikanth; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-08       Impact factor: 3.000

Review 2.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey Thompson; Gary A Rosenberg
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

3.  TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.

Authors:  Jun Miyanohara; Masashi Kakae; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Ken Arai; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-03-09       Impact factor: 6.167

4.  Hypertension and dementia.

Authors:  Costantino Iadecola
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

5.  NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Authors:  Dong-Hee Choi; Kyoung-Hee Lee; Ji-Hye Kim; Ju-Ha Seo; Hahn Young Kim; Chan Young Shin; Jung-Soo Han; Seol-Heui Han; Yoon-Seong Kim; Jongmin Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 6.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

Review 7.  Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?

Authors:  Si-Qi Du; Xue-Rui Wang; Ling-Yong Xiao; Jian-Feng Tu; Wen Zhu; Tian He; Cun-Zhi Liu
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

Review 8.  Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Authors:  Diewertje I Bink; Katja Ritz; Eleonora Aronica; Louise van der Weerd; Mat J A P Daemen
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

9.  Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.

Authors:  Jiangyong Miao; Lina Wang; Xiangjian Zhang; Chunhua Zhu; Lili Cui; Hui Ji; Ying Liu; Xiaolu Wang
Journal:  Neurochem Res       Date:  2016-05-14       Impact factor: 3.996

10.  Ginsenoside Reduces Cognitive Impairment During Chronic Cerebral Hypoperfusion Through Brain-Derived Neurotrophic Factor Regulated by Epigenetic Modulation.

Authors:  Qun Wan; Xue Ma; Zhi-Jun Zhang; Ting Sun; Feng Xia; Gang Zhao; Yu-Mei Wu
Journal:  Mol Neurobiol       Date:  2016-03-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.